13F filer · CIK 2100119 ↗
Vanguard Capital Management
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$2.35T
−20% on the quarter before
Positions
4,081
69 new · 112 sold out
Top 10
18.9%
of the value
Est. gain
−$637.00B
on stocks held all quarter
Est. return
−21.8%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Vanguard Capital Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$2.60BAdded · 3.4% → 4.3%+16,505,291 shares
- Apple~$1.88BAdded · 3.3% → 3.6%+7,405,176 shares
- Amazon~$1.78BAdded · 2.0% → 2.7%+911,807 shares
- Trane Technologies Plc~$1.53BNew · 0.0% → 0.1%+18,469,746 shares
- Centene Corp Del~$1.27BAdded · 0.1% → 0.2%+21,411,135 shares
- Prologis~$1.15BAdded · 0.3% → 0.3%+14,276,788 shares
- Essential Utils Inc~$973.9MNew · 0.0% → 0.0%+23,928,704 shares
- Meta~$801.7MAdded · 1.3% → 1.3%+4,806,611 shares
- Ingersoll Rand Inc~$783.5MNew · 0.0% → 0.0%+31,591,303 shares
- Johnson & Johnson~$723.6MAdded · 1.1% → 1.3%+5,518,363 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ingersoll-Rand Plc~$2.39BSold out · 0.1% → 0.0%−17,974,014 shares
- Wellcare Health Plans Inc~$1.83BSold out · 0.1% → 0.0%−5,555,347 shares
- Liberty Ppty Tr~$1.41BSold out · 0.0% → 0.0%−23,403,350 shares
- Axa Equitable Hldgs Inc~$1.16BSold out · 0.0% → 0.0%−46,624,025 shares
- Aqua America Inc~$1.09BSold out · 0.0% → 0.0%−23,312,963 shares
- Zayo Group Hldgs Inc~$749.3MSold out · 0.0% → 0.0%−21,623,662 shares
- Medicines Co~$648.3MSold out · 0.0% → 0.0%−7,632,116 shares
- Gardner Denver Hldgs Inc~$431.0MSold out · 0.0% → 0.0%−11,749,523 shares
- Senior Hsg Pptys Tr~$306.6MSold out · 0.0% → 0.0%−36,327,099 shares
- Pattern Energy Group Inc~$251.1MSold out · 0.0% → 0.0%−9,386,543 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +2.6% · price +0.0% | 4.3% | $100.96B | +$6.2M | ||||||||
| AppleCOM · shares +2.2% · price −13.4% | 3.6% | $85.63B | −$12.96B | ||||||||
| AmazonCOM · shares +2.8% · price +5.5% | 2.7% | $64.29B | +$3.27B | ||||||||
| MetaCL A · shares +2.6% · price −18.7% | 1.3% | $31.50B | −$7.08B | ||||||||
| Johnson & JohnsonCOM · shares +2.4% · price −10.1% | 1.3% | $30.66B | −$3.37B | ||||||||
| AlphabetCAP STK CL A · shares +2.7% · price −13.2% | 1.2% | $27.37B | −$4.07B | ||||||||
| AlphabetCAP STK CL C · shares +2.3% · price −13.0% | 1.1% | $26.93B | −$3.94B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +2.8% · price −19.3% | 1.1% | $26.67B | −$6.20B | ||||||||
| Procter & Gamble CoCOM · shares +2.6% · price −11.9% | 1.1% | $25.22B | −$3.33B | ||||||||
| Visa Inc.COM CL A · shares +2.7% · price −14.3% | 1.0% | $24.47B | −$3.96B | ||||||||
| Jpmorgan Chase & CoCOM · shares −0.8% · price −35.4% | 0.94% | $22.05B | −$12.09B | ||||||||
| IntelCOM · shares +2.4% · price −9.6% | 0.85% | $20.01B | −$2.07B | ||||||||
| Unitedhealth Group IncCOM · shares +2.6% · price −15.2% | 0.80% | $18.72B | −$3.26B | ||||||||
| Verizon Communications IncCOM · shares +3.1% · price −12.5% | 0.78% | $18.19B | −$2.52B | ||||||||
| MastercardCL A · shares +2.6% · price −19.1% | 0.76% | $17.73B | −$4.08B | ||||||||
| AT&TCOM · shares +3.2% · price −25.4% | 0.74% | $17.39B | −$5.74B | ||||||||
| Merck & Co. IncCOM · shares +3.1% · price −15.4% | 0.71% | $16.70B | −$2.95B | ||||||||
| Home Depot IncCOM · shares +2.4% · price −14.5% | 0.68% | $16.03B | −$2.66B | ||||||||
| Walmart IncCOM · shares +2.9% · price −4.4% | 0.67% | $15.64B | −$698.5M | ||||||||
| Pfizer IncCOM · shares +2.7% · price −16.7% | 0.64% | $15.08B | −$2.94B | ||||||||
| Coca Cola CoCOM · shares +3.1% · price −20.1% | 0.62% | $14.48B | −$3.52B | ||||||||
| Comcast Corp NewCL A · shares +3.1% · price −23.5% | 0.61% | $14.30B | −$4.27B | ||||||||
| CiscoCOM · shares +2.7% · price −18.0% | 0.61% | $14.24B | −$3.05B | ||||||||
| Pepsico IncCOM · shares +2.5% · price −12.1% | 0.60% | $14.11B | −$1.90B | ||||||||
| Exxon Mobil CorpCOM · shares +3.8% · price −45.6% | 0.59% | $13.93B | −$11.25B | ||||||||
| Total · 4,081 positions | 100% | $2.35T | −$637.00B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 4,011 stocks held throughout, down $637.00B (−21.8%).
- Amazon+$3.27B+6%
- Netflix+$1.73B+16%
- Nvidia+$1.34B+12%
- Gilead Sciences Inc+$1.01B+15%
- Tesla+$888.2M+25%
- Wells Fargo Co New−$7.82B−47%
- Bk Of America Corp−$8.68B−40%
- Exxon Mobil Corp−$11.25B−46%
- Jpmorgan Chase & Co−$12.09B−35%
- Apple−$12.96B−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 8 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $4.68T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 (amended) | $4.00T−42% | SEC ↗ |
| Q4 2025 | Jan 29, 2026 | $6.90T+3% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 | $6.68T+8% | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | $6.18T+12% | SEC ↗ |
| Q1 2025 | May 9, 2025 | $5.53T−4% | SEC ↗ |
| Q4 2024 | Feb 11, 2025 | $5.74T+3% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $5.58T+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $5.21T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $5.05T+10% | SEC ↗ |
| Q4 2023 | Mar 11, 2024 (amended) | $4.58T+12% | SEC ↗ |
| Q3 2023 | Dec 18, 2023 (amended) | $4.07T−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $4.22T+7% | SEC ↗ |
| Q1 2023 | Jul 14, 2023 (amended) | $3.93T+7% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $3.67T+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $3.40T−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.56T−16% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $4.23T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $4.40T+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $4.03T+0% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $4.02T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $3.70T+7% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $3.45T+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.02T+7% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.82T+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.35T−20% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.93T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.70T+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $2.66T+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.55T+15% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $2.23T−13% | SEC ↗ |
| Q3 2018 | Dec 13, 2018 (amended) | $2.56T+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.39T+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $2.29T−0% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $2.29T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.14T+5% | SEC ↗ |
| Q2 2017 | Aug 24, 2017 (amended) | $2.03T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.95T+9% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.79T+5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.70T+6% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $1.61T+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $1.54T | SEC ↗ |